ARCHIVES

Advisors Approve CCOP, EDRN, Pediatric Brain Tumor Network Renewal

This article is from The Cancer Letter archive.

Vol. 29 No. 13 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

Clearinghouse Group Selects 10 More Compounds To Test

January 13, 1978

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Biomed Research Absent from Bush State of the Union.

January 26, 2007